Fetal left ventricular myocardial performance index measured at 11–14 weeks of gestation in fetuses with an increased nuchal translucency
- 23 January 2023
- journal article
- research article
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 49 (4) , 1121-1128
Abstract
Objective: This study aimed to evaluate the effect of an increase in nuchal translucency (NT) thickness on the myocardial performance index (MPI) in fetuses without cardiac anomaly in the first trimester and to determine whether a difference in MPI between those with and without trisomy 21 in these fetuses could be determined.Methods: The study group consisted of 53 pregnancies complicated with increased NT thickness without any associated structural anomalies. Forty‐six gestational age‐matched pregnant women whose fetuses had normal NT thickness were enrolled as the control group.Results: In the increased NT thickness group, the mean isovolumetric relaxation time (IRT) value (0.050 ± 0.011 s) was significantly higher and the mean ejection time (ET) value (0.149 ± 0.010 s) was significantly lower than those values in the normal NT thickness group (0.045 ± 0.005 and 0.155 ± 0.009 s, p = 0.023 and p = 0.009, respectively). We found a significantly higher mean left MPI value in the increased NT thickness group (0.574 ± 0.153) versus the normal NT thickness group (0.487 ± 0.107, p < 0.001). Within the increased NT thickness group, the mean left MPI value was similar in the fetuses with normal karyotype and those with trisomy 21 (p = 0.419).Conclusion: We demonstrated a significantly greater mean MPI value in the increased NT thickness group than in the normal NT thickness group. Within the increased NT thickness group, no differences in the left MPI value in the fetuses with normal karyotype and the fetuses with trisomy 21 were found.Keywords
This publication has 26 references indexed in Scilit:
- Normal Reference Ranges from 11 to 41 Weeks’ Gestation of Fetal Left Modified Myocardial Performance Index by Conventional Doppler with the Use of Stringent Criteria for Delimitation of the Time PeriodsFetal Diagnosis and Therapy, 2012
- Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of ageUltrasound in Obstetrics & Gynecology, 2011
- Measurement of Cardiac Contractility Using Fetal Isovolumetric Contraction Time in Fetal TachyarrhythmiaUltrasound in Medicine & Biology, 2011
- Cardiac function in trisomy 21 fetusesUltrasound in Obstetrics & Gynecology, 2010
- Fetal cardiac function between 11 and 35 weeks' gestation and nuchal translucency thicknessUltrasound in Obstetrics & Gynecology, 2010
- Structural heart defects associated with an increased nuchal translucency: 9 years experience in a referral centrePrenatal Diagnosis, 2008
- A modified myocardial performance (Tei) index based on the use of valve clicks improves reproducibility of fetal left cardiac function assessmentUltrasound in Obstetrics & Gynecology, 2005
- Increased nuchal translucency with normal karyotypeAmerican Journal of Obstetrics and Gynecology, 2005
- Doppler assessment of cardiac function at 11–14 weeks' gestation in fetuses with normal and increased nuchal translucencyUltrasound in Obstetrics & Gynecology, 2004
- Fetal cardiac function assessed by Doppler myocardial performance index (Tei Index)Ultrasound in Obstetrics & Gynecology, 2003